Metronidazole and hydroxymetronidazole central nervous system distribution: 2. Cerebrospinal fluid concentration measurements in patients with external ventricular drain

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1024-1027

  Frasca, Denis ^a,b,c   Dahyot Fizelier, Claire ^a,b,c   Adier, Christophe ^a,c   Mimoz, Olivier ^a,b,c   Debaene, Bertrand ^a,b,c   Couet, William ^a,b,c   Marchand, Sandrine ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETRONIDAZOLE; METRONIDAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN INJURY; CASE REPORT; CENTRAL NERVOUS SYSTEM; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; VENTRICULOSTOMY CATHETER;

AGED; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOTRANSFORMATION; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CEREBRAL VENTRICLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRAINAGE; EXTRACELLULAR FLUID; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED;

EID: 84893449293     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01762-13     Document Type: Article

References (23)

1. de Lange EC. 2013. Utility of CSF in translational neuroscience. J. Pharmacokinet. Pharmacodyn. 40:315-326. http://dx.doi.org/10.1007/s10928-013- 9301-9.
2. Westerhout J, Danhof M, De Lange EC. 2011. Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting. J. Pharm. Sci. 100:3577-3593. http://dx.doi.org/10.1002/jps. 22604.
3. Dahyot-Fizelier C, Timofeev I, Marchand S, Hutchinson P, Debaene B, Menon D, Mimoz O, Gupta A, Couet W. 2010. Brain microdialysis study of meropenem in two patients with acute brain injury. Antimicrob. Agents Chemother. 54:3502-3504. http://dx.doi.org/10.1128/AAC.01725-09.
4. Dahyot-Fizelier C, Frasca D, Gregoire N, Adier C, Mimoz O, Debaene B, Couet W, Marchand S. 2013. Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury. Antimicrob. Agents Chemother. 57:2738-2742. http://dx.doi.org/10.1128/AAC.02570-12.
5. Westerhout J, Ploeger B, Smeets J, Danhof M, de Lange EC. 2012. Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats. AAPS J. 14:543-553. http://dx.doi.org/10.1208/ s12248-012-9366-1.
6. Westerhout J, Smeets J, Danhof M, de Lange EC. 2013. The impact of P-gp functionality on non-steady-state relationships between CSF and brain extracellular fluid. J. Pharmacokinet. Pharmacodyn. 40:327-342. http://dx.doi.org/10.1007/s10928-013-9314-4.
7. Rambeck B, Jurgens UH, May TW, Pannek HW, Behne F, Ebner A, Gorji A, Straub H, Speckmann EJ, Pohlmann-Eden B, Loscher W. 2006. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47:681-694. http://dx.doi.org/10.1111/j.1528-1167.2006. 00504.x.
8. Shin SH, Kim KS. 2012. Treatment of bacterial meningitis: an update. Expert Opin. Pharmacother. 13:2189-2206. http://dx.doi.org/10.1517/14656566. 2012.724399.
9. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. 1980. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79:599.
10. Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. 2007. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. Am. J. Neuroradiol. 28:1652-1658. http://dx.doi.org/10.3174/ ajnr.A0655.
11. Patel K, Green-Hopkins I, Lu S, Tunkel AR. 2008. Cerebellar ataxia following prolonged use of metronidazole: case report and literature review. Int. J. Infect. Dis. 12:e111-e114. http://dx.doi.org/10.1016/j.ijid.2008.03.006.
12. Seok JI, Yi H, Song YM, Lee WY. 2003. Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusionweighted imaging and apparent diffusion coefficient maps. Arch. Neurol. 60:1796-1800. http://dx.doi.org/10.1001/archneur.60.12.1796.
13. Frasca D, Dahyot-Fizelier C, Adier C, Mimoz O, Debaene B, Couet W, Marchand S. 2014. Metronidazole and hydroxymetronidazole central nervous system distribution: microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury. Antimicrob. Agents Chemother. 58:1019-1023. http://dx.doi.org/10.1128/AAC.01760-13.
14. Regeniter A, Kuhle J, Mehling M, Moller H, Wurster U, Freidank H, Siede WH. 2009. A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting. Clin. Neurol. Neurosurg. 111:313-318. http://dx.doi.org/10.1016/j.clineuro.2008.12.004.
15. Lau AH, Lam NP, Piscitelli SC, Wilkes L, Danziger LH. 1992. Clinical pharmacokinetics of metronidazole and other nitroimidazole antiinfectives. Clin. Pharmacokinet. 23:328-364. http://dx.doi.org/10.2165/00003088-199223050-00002.
16. Lamp KC, Freeman CD, Klutman NE, Lacy MK. 1999. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin. Pharmacokinet. 36:353-373. http://dx.doi.org/10.2165/00003088-199936050-00004.
17. O'Grady LR, Ralph ED. 1976. Anaerobic meningitis and bacteremia caused by Fusobacterium species. Am. J. Dis. Children 130:871-873.
18. Feldman WE. 1976. Bacteroides fragilis ventriculitis and meningitis: Report of two cases. Am. J. Dis. Child. 130:880-883. http://dx.doi.org/10.1001/ archpedi.1976.02120090090017.
19. Jokipii AM, Myllyla VV, Hokkanen E, Jokipii L. 1977. Penetration of the blood brain barrier by metronidazole and tinidazole. J. Antimicrob. Chemother. 3:239-245. http://dx.doi.org/10.1093/jac/3.3.239.
20. Davies AH. 1967. Metronidazole in human infections with syphilis. Br. J. Vener. Dis. 43:197-200.
21. Warner JF, Perkins RL, Cordero L. 1979. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Arch. Intern. Med. 139:167-169. http://dx.doi.org/10.1001/archinte.139.2.167.
22. Soriano F, Aguado JM, Tornero J, Fernandez-Guerrero ML, Gomez-Garces JL. 1986. Bacteroides fragilis meningitis successfully treated with metronidazole after a previous failure with thiamphenicol. J. Clin. Microbiol. 24:472-473.
23. Craig WA. 2007. Pharmacodynamics of antimicrobials: general concepts and applications, p 1-19. In Nightingale CH, Ambrose PG, Drusano GL, Murakawa T (ed), Antimicrobial pharmacodynamics in theory and clinical practice, 2nd ed. Informa Healthcare, New York, NY.